Veröffentlichungsdatum: 25 März 2021
Projektträger – zwischengeschaltetes Finanzinstitut
CREDIT LYONNAISOrt
Beschreibung
The operation is a EUR 200 million multiple beneficiary intermediated loan (MBIL) which aims at facilitating access to long-term finance for projects carried out by professionals/small and medium-sized enterprises (SMEs) active in the healthcare and pharmaceutical sectors in France with a specific 20% window dedicated to regions where access to medical experts is sub-optimal/underserved.
Additionality and Impact
The facility aims at supporting investments made by professionals and SMEs active in the healthcare sector in France with a specific focus on underserved regions.
EIB intervention will enable to improve the competition between FIs active on this market and will improve funding conditions for healthcare professionals (pricing decrease is contractually stated). In addition, through its specific focus on underserved regions, the proposed operation is expected to support professional willing to settle down in these regions where access to medical offer is limited and hence improve citizen's access to medical professional across the territory.
Ziele
Financing of small/medium projects carried out by professionals and SMEs active in the healthcare and pharmaceutical sector in France.
Sektor(en)
- Durchleitungsdarlehen - Durchleitungsdarlehen
Vorgeschlagene EIB-Finanzierung (voraussichtlicher Betrag)
EUR 200 million
Gesamtkosten (voraussichtlicher Betrag)
not applicable
Umweltaspekte
Final beneficiaries will be requested to comply with applicable national and EU legislation, as appropriate.
Auftragsvergabe
Final beneficiaries will be requested to comply with applicable national and EU legislation, as appropriate.
Projektstatus
Unterzeichnet - 7/10/2021
Haftungsausschluss
Bis Finanzierungen vom Verwaltungsrat genehmigt und anschließend unterzeichnet werden, befinden sich die Projekte in der Prüfungs- oder Verhandlungsphase. Die Angaben auf dieser Seite sind daher unverbindlich.
Sie dienen lediglich der Transparenz und stellen nicht die offizielle EIB-Politik dar (vgl. auch die erklärenden Anmerkungen).